Phibro Animal Health Co. (NASDAQ:PAHC) Shares Sold by Pinnacle Associates Ltd.

Pinnacle Associates Ltd. lowered its stake in shares of Phibro Animal Health Co. (NASDAQ:PAHC) by 25.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 24,120 shares of the company’s stock after selling 8,220 shares during the quarter. Pinnacle Associates Ltd. owned about 0.06% of Phibro Animal Health worth $279,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of the stock. Dynamic Advisor Solutions LLC acquired a new position in shares of Phibro Animal Health during the fourth quarter valued at about $208,000. GSA Capital Partners LLP increased its holdings in Phibro Animal Health by 227.0% in the 3rd quarter. GSA Capital Partners LLP now owns 81,647 shares of the company’s stock worth $1,043,000 after buying an additional 56,676 shares during the period. Bridge City Capital LLC increased its holdings in Phibro Animal Health by 4.6% in the 3rd quarter. Bridge City Capital LLC now owns 107,221 shares of the company’s stock worth $1,369,000 after buying an additional 4,740 shares during the period. Qube Research & Technologies Ltd acquired a new position in Phibro Animal Health in the 3rd quarter worth approximately $34,000. Finally, Trexquant Investment LP increased its holdings in Phibro Animal Health by 143.6% in the 3rd quarter. Trexquant Investment LP now owns 35,872 shares of the company’s stock worth $458,000 after buying an additional 21,147 shares during the period. Institutional investors and hedge funds own 99.34% of the company’s stock.

Wall Street Analyst Weigh In

PAHC has been the topic of several research reports. StockNews.com upgraded shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a report on Friday, March 29th. BNP Paribas initiated coverage on shares of Phibro Animal Health in a report on Thursday, December 7th. They issued an “underperform” rating and a $9.00 price target on the stock.

Phibro Animal Health Trading Up 2.9 %

Phibro Animal Health stock opened at $12.93 on Thursday. The company has a current ratio of 3.12, a quick ratio of 1.60 and a debt-to-equity ratio of 1.66. Phibro Animal Health Co. has a 12 month low of $9.40 and a 12 month high of $15.98. The stock’s 50 day simple moving average is $12.28 and its two-hundred day simple moving average is $11.73. The firm has a market cap of $523.67 million, a PE ratio of 35.92, a P/E/G ratio of 4.67 and a beta of 0.75.

Phibro Animal Health (NASDAQ:PAHC) last announced its earnings results on Wednesday, February 7th. The company reported $0.33 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.27 by $0.06. Phibro Animal Health had a return on equity of 16.67% and a net margin of 1.51%. The firm had revenue of $249.90 million for the quarter, compared to analyst estimates of $242.91 million. Analysts anticipate that Phibro Animal Health Co. will post 1.12 earnings per share for the current year.

Phibro Animal Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 27th. Stockholders of record on Wednesday, March 6th were given a dividend of $0.12 per share. The ex-dividend date of this dividend was Tuesday, March 5th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 3.71%. Phibro Animal Health’s dividend payout ratio (DPR) is 133.33%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.